Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysis.

Wu, Mingxin; Mou, Ruiyu; Liu, Xiaodi; Guo, Shanqi; Kong, Fanming; Li, Xiaojiang; Jia, Yingjie

Wu, Mingxin; Mou, Ruiyu; Liu, Xiaodi; Guo, Shanqi; Kong, Fanming; Li, Xiaojiang; Jia, Yingjie.

Afiliação

Wu M; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Mou R; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Liu X; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Guo S; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Kong F; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.
Li X; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Jia Y; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine.

Medicine (Baltimore) ; 100(1): e23877, 2021 Jan 08.

Article em En | MEDLINE | ID: mdl-33429748

Assuntos

COVID-19/complicações; Neoplasias Pulmonares/virologia; Projetos de Pesquisa; Humanos; Metanálise como Assunto; Medição de Risco; Fatores de Risco; SARS-CoV-2; Revisões Sistemáticas como Assunto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / COVID-19 / Neoplasias Pulmonares Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google